Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C4orf32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AP1AR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIFA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PITX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENPEP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELOVL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on